Back
Allogene Therapeutics Stock Price Chart
Access "King of the Quants" Stock Rating System FREE!
[Claim Your 3 Free Grades Now]
Sell
22
ALLO
Allogene Therapeutics
Last Price:
$1.82
Seasonality Move:
-11%
7 Day Trial
ALL ACCESS PASS
$
7
Free Access to "King of the Quants" Stock Rating System
[Claim Your 3 Free Grades Now]-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ALLO is experiencing slight selling pressure.
Allogene Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 2.02 | Sell |
| 20-day SMA: | 2.05 | Sell |
| 50-day SMA: | 2.27 | Sell |
| 200-day SMA: | 2.65 | Sell |
| 8-day EMA: | 1.95 | Sell |
| 20-day EMA: | 2.05 | Sell |
| 50-day EMA: | 2.22 | Sell |
| 200-day EMA: | 2.75 | Sell |
Allogene Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.09 | Sell |
| Relative Strength Index (14 RSI): | 36.71 | Sell |
| Chaikin Money Flow: | -869126 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.89 - 2.19) | Sell |
| Bollinger Bands (100): | (2.13 - 2.83) | Sell |
Allogene Therapeutics Technical Analysis
| Jan 3 | Jan 6 | Jan 7 | Jan 8 | Jan 10 | Jan 13 | Jan 14 | Jan 15 | Jan 16 | Jan 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan | ||||||||||
| 03 | 06 | 07 | 08 | 10 | 13 | 14 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Allogene Therapeutics Stock
Is Allogene Therapeutics Stock a Buy?
-
Allogene Therapeutics share price is 1.82 while ALLO 8-day simple moving average is 2.02, which is a Sell signal.
-
The stock price of ALLO is 1.82 while Allogene Therapeutics 20-day SMA is 2.05, which makes it a Sell.
-
Allogene Therapeutics 50-day simple moving average is 2.27 while ALLO share price is 1.82, making it a Sell technically.
-
ALLO stock price is 1.82 and Allogene Therapeutics 200-day simple moving average is 2.65, creating a Sell signal.
ALLO Technical Analysis vs Fundamental Analysis
Sell
22
Allogene Therapeutics (ALLO)
is a Sell
Is Allogene Therapeutics a Buy or a Sell?
-
Allogene Therapeutics stock is rated a SellThe current Allogene Therapeutics [ALLO] share price is $1.82. The Score for ALLO is 22, which is 56% below its historic median score of 50, and infers higher risk than normal.
Allogene Therapeutics Stock Info
Market Cap:
381.6M
Price in USD:
1.82
Share Volume:
2.2M
Allogene Therapeutics 52-Week Range
52-Week High:
5.78
52-Week Low:
1.78
Sell
22
Allogene Therapeutics (ALLO)
is a Sell
Allogene Therapeutics Share Price Forecast
-
What is the Allogene Therapeutics stock price today?The Allogene Therapeutics stock price is 1.82 USD today.
-
Will ALLO stock go up or go down?Allogene Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Allogene Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Allogene Therapeutics is overvalued.
Is Allogene Therapeutics Stock a Buy?
-
Allogene Therapeutics share price is 1.82 while ALLO 8-day exponential moving average is 1.95, which is a Sell signal.
-
The stock price of ALLO is 1.82 while Allogene Therapeutics 20-day EMA is 2.05, which makes it a Sell.
-
Allogene Therapeutics 50-day exponential moving average is 2.22 while ALLO share price is 1.82, making it a Sell technically.
-
ALLO stock price is 1.82 and Allogene Therapeutics 200-day simple moving average is 2.75, creating a Sell signal.
Fundamental Analysis of Allogene Therapeutics
Is Allogene Therapeutics a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.03 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.08 per share, and a decrease next year of $0.15 per share.
Technical Analysis of Allogene Therapeutics
Should I short Allogene Therapeutics stock?
-
ALLO Moving Average Covergence Divergence (MACD) indicator is -0.09, suggesting Allogene Therapeutics is a Sell
-
Allogene Therapeutics Relative Strength Index (RSI) is 36.71, which suggest Allogene Therapeutics is oversold
-
The Bollinger Bands (25) for Allogene Therapeutics is (1.89 - 2.19), which suggest Allogene Therapeutics is a Sell
-
The Bollinger Bands (100) for Allogene Therapeutics is (2.13 - 2.83), which suggest Allogene Therapeutics is a Sell
* Allogene Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.